136 related articles for article (PubMed ID: 24718793)
21. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.
Houssaini A; Abid S; Mouraret N; Wan F; Rideau D; Saker M; Marcos E; Tissot CM; Dubois-Randé JL; Amsellem V; Adnot S
Am J Respir Cell Mol Biol; 2013 May; 48(5):568-77. PubMed ID: 23470622
[TBL] [Abstract][Full Text] [Related]
22. Small-molecule-based nanoassemblies as inducible nanoprobes for monitoring dynamic molecular interactions inside live cells.
Lee S; Lee KH; Ha JS; Lee SG; Kim TK
Angew Chem Int Ed Engl; 2011 Sep; 50(37):8709-13. PubMed ID: 21796746
[No Abstract] [Full Text] [Related]
23. Characterization of an Engineered Src Kinase to Study Src Signaling and Biology.
Gentry LR; Karginov AV; Hahn KM; Der CJ
Methods Mol Biol; 2016; 1360():157-67. PubMed ID: 26501909
[TBL] [Abstract][Full Text] [Related]
24. Sindbis virus replication, is insensitive to rapamycin and torin1, and suppresses Akt/mTOR pathway late during infection in HEK cells.
Mohankumar V; Dhanushkodi NR; Raju R
Biochem Biophys Res Commun; 2011 Mar; 406(2):262-7. PubMed ID: 21316343
[TBL] [Abstract][Full Text] [Related]
25. GATA-Dependent Glutaminolysis Drives Appressorium Formation in Magnaporthe oryzae by Suppressing TOR Inhibition of cAMP/PKA Signaling.
Marroquin-Guzman M; Wilson RA
PLoS Pathog; 2015 Apr; 11(4):e1004851. PubMed ID: 25901357
[TBL] [Abstract][Full Text] [Related]
26. mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.
Boudra R; Lagrafeuille R; Lours-Calet C; de Joussineau C; Loubeau-Legros G; Chaveroux C; Saru JP; Baron S; Morel L; Beaudoin C
Cell Cycle; 2016 May; 15(10):1352-62. PubMed ID: 27050906
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the rapamycin-inducible EBV LMP1 activation system.
Kim SY; Kim JE; Won J; Song YJ
J Microbiol; 2015 Oct; 53(10):732-8. PubMed ID: 26428925
[TBL] [Abstract][Full Text] [Related]
28. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.
Kawauchi K; Ihjima K; Yamada O
J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522
[TBL] [Abstract][Full Text] [Related]
29. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.
Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR
Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051
[TBL] [Abstract][Full Text] [Related]
30. Flow-induced DNA synthesis requires signaling to a translational control pathway.
Kraiss LW; Ennis TM; Alto NM
J Surg Res; 2001 May; 97(1):20-6. PubMed ID: 11319875
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of protein synthesis by TOR inactivation revealed a conserved regulatory mechanism of the BiP chaperone in Chlamydomonas.
Díaz-Troya S; Pérez-Pérez ME; Pérez-Martín M; Moes S; Jeno P; Florencio FJ; Crespo JL
Plant Physiol; 2011 Oct; 157(2):730-41. PubMed ID: 21825107
[TBL] [Abstract][Full Text] [Related]
32. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
33. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
[TBL] [Abstract][Full Text] [Related]
34. LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway.
Chen Z; Yang L; Liu Y; Tang A; Li X; Zhang J; Yang Z
Mol Cell Biochem; 2014 Jan; 385(1-2):169-77. PubMed ID: 24072614
[TBL] [Abstract][Full Text] [Related]
35. Are invertebrates relevant models in ageing research? Focus on the effects of rapamycin on TOR.
Erdogan CS; Hansen BW; Vang O
Mech Ageing Dev; 2016 Jan; 153():22-9. PubMed ID: 26763146
[TBL] [Abstract][Full Text] [Related]
36. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
38. Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
Garelick MG; Mackay VL; Yanagida A; Academia EC; Schreiber KH; Ladiges WC; Kennedy BK
Cell Cycle; 2013 Aug; 12(15):2493-504. PubMed ID: 23839034
[TBL] [Abstract][Full Text] [Related]
39. Both PI3K- and mTOR-signaling pathways take part in CVB3-induced apoptosis of Hela cells.
Li X; Zhang J; Chen Z; Yang L; Xing X; Ma X; Yang Z
DNA Cell Biol; 2013 Jul; 32(7):359-70. PubMed ID: 23705975
[TBL] [Abstract][Full Text] [Related]
40. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
Salh B; Wagey R; Marotta A; Tao JS; Pelech S
J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
